LONDON — Officials with drugmaker AstraZeneca have asked the U.S. Food and Drug Administration to authorize the emergency use of an antibody treatment to prevent COVID-19.
The company says the treatment, known as AZD7442, will be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention. AstraZeneca says the drug may help protect people whose immune systems don’t fully respond to vaccination.
U.S. demand for antibody treatments soared over the summer, particularly in Florida, Louisiana and Texas, where hospitalizations among unvaccinated patients threatened to overwhelm the health care system.
The drugs are lab versions of virus-blocking antibodies that help fight off infections. The treatments help the patient by supplying concentrated doses. The main antibody treatment used in the U.S. is Regeneron’s dual-antibody cocktail.
WASHINGTON (AP) — Anthony Fauci, former chief White House medical adviser, is expected to testify before Congress early next year as part of Republicans' yearslong investigation into the origins of COVID-19 and the U.
FALMOUTH, MA – The police in Falmouth have identified the victim in an accident involving a car plunging into the ocean on February 20, NBC10 Boston reported.
A mother and her 14-year-old daughter are advocating for better protections for victims after AI-generated nude images of the teen and other female classmates were circulated at a high school in New Jersey.
A mother and her 14-year-old daughter are advocating for better protections for victims after AI-generated nude images of the teen and other female classmates were circulated at a high school in New Jersey.
MUNICH (AP) — Bayern Munich’s home game against Union Berlin was called off Saturday because of heavy snowfall.
DUBAI, United Arab Emirates (AP) — Countries once colonized by empires are striking back on global warming — and they have the pope's blessing.
MOSCOW (AP) — Imprisoned opposition leader Alexei Navalny has been handed new charges by Russian prosecutors.
Explore articles from the past and connect to your heritage!
Discover the benefits of a subscription including access to exclusive content, events, and more!
Have an idea for a story, or know of an event we should cover? We want to hear about it!
The National Herald is the paper of record of the Greek Diaspora community. Through independent journalism, we bring news to generations of Greek-Americans, with stories on the individual, community and international level. Visit and support our 106 year-old sister publication Εθνικός Κήρυξ.
To purchase a gift subscription, please log out of your account, and purchase the subscription with a new email ID.
Sign up to receive our daily email news briefing.
Sign up for a subscription to The National Herald,
starting as low as $1/week.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
and receive more access to The National Herald
View our Terms of Service + Privacy Policy.
We use cookies on our site to personalize your experience, bring you the most relevant content, show you the most useful ads, and to help report any issues with our site. You can update your preferences at any time by visiting preferences. By selecting Accept, you consent to our use of cookies. To learn more about how your data is used, visit our cookie policy.
$1.09 USD
